The Lobbying Register, read carefully Epicycle

Returns

Every filed return on the register. Filter, then open any return on lobbying.ie to read it in full.

Clear all

Showing returns filed by Hanover Media Strategy Limited naming Louise O'Reilly .

Filed returns
27
match these filters
Matching filed returns per period 0 1 2 3 5 Jan–Apr 2017: 1 filed returns May–Aug 2017: 3 filed returns Sep–Dec 2017: 2 filed returns Jan–Apr 2018: 2 filed returns May–Aug 2018: 1 filed returns Sep–Dec 2018: 1 filed returns Jan–Apr 2019: 1 filed returns May–Aug 2019: 1 filed returns Jan–Apr 2020: 4 filed returns May–Aug 2020: 1 filed returns Sep–Dec 2020: 3 filed returns Jan–Apr 2021: 2 filed returns May–Aug 2022: 1 filed returns May–Aug 2023: 2 filed returns Sep–Dec 2023: 1 filed returns Sep–Dec 2024: 1 filed returns 2017 2018 2019 2020 2021
Filed returns per four-month period Click a column to list its returns.
PeriodRegistrantPolicy areaSubject, as filedOfficials namedLink
Sep–Dec 2024 Hanover Media Strategy Limited Health Life Sciences Strategy for Ireland (Public policy or programme) 10 On lobbying.ie
Sep–Dec 2023 Hanover Media Strategy Limited Economic Development and Industry Meeting requests on foot of 21st Century Infrastructure: Accelerating Delivery of the National Digital Strategy (Public policy or programme) 4 On lobbying.ie
May–Aug 2023 Hanover Media Strategy Limited Economic Development and Industry Sharing key policy documents with key stakeholders across Goverment (Public policy or programme) 77 On lobbying.ie
May–Aug 2023 Hanover Media Strategy Limited Economic Development and Industry Circulation of policy paper on '21st Century Infrastructure: Accelerating Delivery of the National Digital Strategy' (Public policy or programme) 6 On lobbying.ie
May–Aug 2022 Hanover Media Strategy Limited Energy and Natural Resources Ocean Winds' offshore wind projects in Ireland (Zoning or development) 62 On lobbying.ie
Jan–Apr 2021 Hanover Media Strategy Limited Health Treatment of Irish patients with Amyloidosis in Ireland and reimbursement pathway for Alnylam medicines (Matters involving public funds) 15 On lobbying.ie
Jan–Apr 2021 Hanover Media Strategy Limited Finance Cost of Motor Insurance Policies in Ireland (Public policy or programme) 5 On lobbying.ie
Sep–Dec 2020 Hanover Media Strategy Limited Finance The impact of Covid-19 on the car rental industry (Public policy or programme) 20 On lobbying.ie
Sep–Dec 2020 Hanover Media Strategy Limited Health Treatment of Irish patients with Amyloidosis in Ireland and reimbursement pathway for Alnylam medicines (Matters involving public funds) 14 On lobbying.ie
Sep–Dec 2020 Hanover Media Strategy Limited Transport Cost of Motor Insurance Policies in Ireland (Public policy or programme) 85 On lobbying.ie
May–Aug 2020 Hanover Media Strategy Limited Health The reimbursement process and pathway affecting AstraZeneca medicines (Matters involving public funds) 10 On lobbying.ie
Jan–Apr 2020 Hanover Media Strategy Limited Health Treatment of Irish patients with Amyloidosis in Ireland and reimbursement pathway for Alnylam medicines (Matters involving public funds) 5 On lobbying.ie
Jan–Apr 2020 Hanover Media Strategy Limited Health Creation of national policy with regard to Orphan Medicinal Products (Legislation) 4 On lobbying.ie
Jan–Apr 2020 Hanover Media Strategy Limited Transport The impact of COVID-19 on the tourism sector in Ireland, and the specific impact it is having the Irish car rental industry (Legislation) 20 On lobbying.ie
Jan–Apr 2020 Hanover Media Strategy Limited Health Optimisation of Rheumatoid Arthritis pathway of care (Matters involving public funds) 10 On lobbying.ie
May–Aug 2019 Hanover Media Strategy Limited Health The reimbursement process and pathway affecting AstraZeneca medicines & engage government on healthcare innovation (Matters involving public funds) 15 On lobbying.ie
Jan–Apr 2019 Hanover Media Strategy Limited Health The reimbursement process and pathway affecting AstraZeneca medicines (Matters involving public funds) 10 On lobbying.ie
Sep–Dec 2018 Hanover Media Strategy Limited Health Creation of national policy to increase availability of Orphan Medicinal Products (Legislation) 10 On lobbying.ie
May–Aug 2018 Hanover Media Strategy Limited Health Creation of national policy to increase availability of Orphan Medicinal Products (Legislation) 13 On lobbying.ie
Jan–Apr 2018 Hanover Media Strategy Limited Health Reimbursement of Vimizim for Morquio A Syndrome (Matters involving public funds) 12 On lobbying.ie
Jan–Apr 2018 Hanover Media Strategy Limited Health Creation of national policy to increase availability of Orphan Medicinal Products (Legislation) 12 On lobbying.ie
Sep–Dec 2017 Hanover Media Strategy Limited Health Reimbursement of Translarna for nonsense mutation Duchenne Muscular Dystrophy (Public policy or programme) 16 On lobbying.ie
Sep–Dec 2017 Hanover Media Strategy Limited Health Creation of national policy to increase availability of Orphan Medicinal Products (Legislation) 8 On lobbying.ie
May–Aug 2017 Hanover Media Strategy Limited Health Reimbursement of Translarna for nonsense mutation Duchenne Muscular Dystrophy (Matters involving public funds) 18 On lobbying.ie
May–Aug 2017 Hanover Media Strategy Limited Health Reimbursement of Vimizim for Morquio A Syndome (Matters involving public funds) 8 On lobbying.ie
May–Aug 2017 Hanover Media Strategy Limited Health Rare Disease Medicines (Public policy or programme) 11 On lobbying.ie
Jan–Apr 2017 Hanover Media Strategy Limited Health Reimbursement of Translarna for nonsense mutation Duchenne Muscular Dystrophy (Matters involving public funds) 19 On lobbying.ie

Policy areas in these returns

Public policy areaFiled returnsShareRelative to the largest
Health 19 70.4%
Economic Development and Industry 3 11.1%
Finance 2 7.4%
Transport 2 7.4%
Energy and Natural Resources 1 3.7%